These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8716998)

  • 41. Association between sexual behavior and cervical cancer screening.
    Smith AM; Heywood W; Ryall R; Shelley JM; Pitts MK; Richters J; Simpson JM; Patrick K
    J Womens Health (Larchmt); 2011 Jul; 20(7):1091-6. PubMed ID: 21682554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ViraPap: can it help to reduce the need for colposcopy?
    Mareck DG; Woolard DG
    Fam Pract Res J; 1991 Dec; 11(4):405-14. PubMed ID: 1662859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The politics of pap smears.
    Spencer C
    Contemp Nurse; 1995 Sep; 4(3):139. PubMed ID: 8696035
    [No Abstract]   [Full Text] [Related]  

  • 44. Factors affecting non-response to cervical cytology screening in Norfolk, England.
    Bentham G; Hinton J; Haynes R; Lovett A; Bestwick C
    Soc Sci Med; 1995 Jan; 40(1):131-5. PubMed ID: 7899917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervicography: an alternative modality of cervical screening.
    Burke L
    Diagn Cytopathol; 1991; 7(6):631-2. PubMed ID: 1769294
    [No Abstract]   [Full Text] [Related]  

  • 46. A survey of the cervical screening service in a London district, including reasons for non-attendance, ethnic responses and views on the quality of the service.
    Doyle Y
    Soc Sci Med; 1991; 32(8):953-7. PubMed ID: 2031211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economics, politics, and the examination room: Pap testing in Italy.
    Attanasio AE
    Lancet; 1996 Mar; 347(9002):694-5. PubMed ID: 8596413
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytological surveillance for mild cervical dyskaryosis.
    Luesley D; Shafi M
    Lancet; 1992 Aug; 340(8818):552-3. PubMed ID: 1354305
    [No Abstract]   [Full Text] [Related]  

  • 49. Wait, what are we screening for again?
    Tarczy-Hornoch K
    J AAPOS; 2022 Apr; 26(2):55-57. PubMed ID: 35314314
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation and follow-up of abnormal Pap smears.
    Miller KE; Losh DP; Folley A
    Am Fam Physician; 1992 Jan; 45(1):143-50. PubMed ID: 1309403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The politics of pap smears.
    Thompson J
    Contemp Nurse; 1996 Mar; 5(1):4. PubMed ID: 8716998
    [No Abstract]   [Full Text] [Related]  

  • 52. Managing abnormal Pap smears: comments on two articles.
    Buck HW
    J Am Coll Health; 1989 Sep; 38(2):101-2. PubMed ID: 2778225
    [No Abstract]   [Full Text] [Related]  

  • 53. Cervical screening in practice.
    Fenwicke R
    N Z Med J; 1989 Jul; 102(872):386. PubMed ID: 2797560
    [No Abstract]   [Full Text] [Related]  

  • 54. [Can microcolpohysteroscopy be used to screen cervical lesions?].
    Hamou J; Frydman R; Fernandez H; Capella S; Taylor S
    Contracept Fertil Sex; 1997 May; 25(5):358-62. PubMed ID: 9273106
    [No Abstract]   [Full Text] [Related]  

  • 55. [Four years of screening cervical smears of cervical lesions].
    Autillo-Touati A; Benmoura D; Palazzi D; Robaglia A; Tasso F; Blanc B; Seite R
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(7):754-60. PubMed ID: 1469229
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.